PDGFRA Amplification is Common in Pediatric and Adult High‐Grade Astrocytomas and Identifies a Poor Prognostic Group in IDH 1 Mutant Glioblastoma

• Published in: Brain pathology (Zurich, Switzerland) Switzerland), 2013-09, Vol.23 (5), p.565-573
• Main Authors: Phillips, Joanna J., Aranda, Derick, Ellison, David W., Judkins, Alexander R., Croul, Sidney E., Brat, Daniel J., Ligon, Keith L., Horbinski, Craig, Venneti, Sriram, Zadeh, Gelareh, Santi, Mariarita, Zhou, Shengmei, Appin, Christina L., Sioletic, Stefano, Sullivan, Lisa M., Martinez‐Lage, Maria, Robinson, Aaron E., Yong, William H., Cloughesy, Timothy, Lai, Albert, Phillips, Heidi S., Marshall, Roxanne, Mueller, Sabine, Haas‐Kogan, Daphne A., Molinaro, Annette M., Perry, Arie
• Format: Article
• Language: English
• ISSN: 1015-6305; 1750-3639
• DOI: 10.1111/bpa.12043

High‐grade astrocytomas ( HGAs ), corresponding to W orld H ealth O rganization grades III (anaplastic astrocytoma) and IV (glioblastoma; GBM ), are biologically aggressive, and their molecular classification is increasingly relevant to clinical management. PDGFRA amplification is common in HGAs , although its prognostic significance remains unclear. Using fluorescence in situ hybridization ( FISH ), the most sensitive technique for detecting PDGFRA copy number gains, we determined PDGFRA amplification status in 123 pediatric and 263 adult HGAs . A range of PDGFRA FISH patterns were identified and cases were scored as non‐amplified (normal and polysomy) or amplified (low‐level and high‐level). PDGFRA amplification was frequent in pediatric (29.3%) and adult (20.9%) tumors. Amplification was not prognostic in pediatric HGAs . In adult tumors diagnosed initially as GBM , the presence of combined PDGFRA amplification and isocitrate dehydrogenase 1 ( IDH 1) R132H mutation was a significant independent prognostic factor ( P  = 0.01). In HGAs , PDGFRA amplification is common and can manifest as high‐level and focal or low‐level amplifications. Our data indicate that the latter is more prevalent than previously reported with copy number averaging techniques. To our knowledge, this is the largest survey of PDGFRA status in adult and pediatric HGAs and suggests PDGFRA amplification increases with grade and is associated with a less favorable prognosis in IDH 1 mutant de novo GBMs .